Abdel-Hafiz, H.A. 2017. Epigenetic mechanisms of tamoxifen resistance in luminal breast cancer. Diseases, 5(3): 16.
Behdarvand, N., Torbati, M.B. and Shaabanzadeh, M. 2020. Tamoxifen-loaded pla/dppe-peg lipid-polymeric nanocapsules for inhibiting the growth of estrogen-positive human breast cancer cells through cell cycle arrest. Journal of Nanoparticle Research, 22(9): 1-15.
De Oliveira, C.P., Büttenbender, S.L., Prado, W.A., Beckenkamp, A., Asbahr, A.C., Buffon, A., Guterres, S.S. and Pohlmann, A.R. 2018. Enhanced and selective antiproliferative activity of methotrexate-functionalized-nanocapsules to human breast cancer cells (mcf-7). Nanomaterials, 8(1): 24.
Dong, P., Rakesh, K., Manukumar, H., Mohammed, Y.H.E., Karthik, C., Sumathi, S., Mallu, P. and Qin, H.-L. 2019. Innovative nano-carriers in anticancer drug delivery-a comprehensive review. Bioorganic chemistry, 85: 325-336.
Gakhar, G., Hua, D.H. and Nguyen, T.A. 2010. Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells. Anti-cancer drugs, 21(1): 77.
Guven, A., Rusakova, I.A., Lewis, M.T. and Wilson, L.J. 2012. Cisplatin@ us-tube carbon nanocapsules for enhanced chemotherapeutic delivery. Biomaterials, 33(5): 1455-1461.
Han, N.-n., Zhou, Q., Huang, Q. and Liu, K.-j. 2017. Carnosic acid cooperates with tamoxifen to induce apoptosis associated with caspase-3 activation in breast cancer cells in vitro and in vivo. Biomedicine & Pharmacotherapy, 89: 827-837.
Hekmat, A., Afrough, M., Hesami Tackallou, S. and Ahmad, F. 2020. Synergistic effects of titanium dioxide nanoparticles and paclitaxel combination on the DNA structure and their antiproliferative role on mda-mb-231cells. Journal of Nanoanalysis: -. DOI 10.22034/jna.2020.1869287.1141.
Hekmat, A. and Roshani, Z. 2020. The effects of silver nanoparticles coatings in effective drug delivery: Human serum albumin interaction. Journal of Fasa University of Medical Sciences, 10(2): 2294-2307.
Hultsch, S., Kankainen, M., Paavolainen, L., Kovanen, R.-M., Ikonen, E., Kangaspeska, S., Pietiäinen, V. and Kallioniemi, O. 2018. Association of tamoxifen resistance and lipid reprogramming in breast cancer. BMC cancer, 18(1): 1-14.
Kathle, P.K., Gautam, N. and Kesavan, K. 2018. Tamoxifen citrate loaded chitosan-gellan nanocapsules for breast cancer therapy: Development, characterisation and in-vitro cell viability study. Journal of microencapsulation, 35(3): 292-300.
Kim, R. 2005. Unknotting the roles of bcl-2 and bcl-xl in cell death. Biochemical and biophysical research communications, 333(2): 336-343.
Kumari, P., Ghosh, B. and Biswas, S. 2016. Nanocarriers for cancer-targeted drug delivery. Journal of drug targeting, 24(3): 179-191.
Lila, A.S.A., Kiwada, H. and Ishida, T. 2014. Selective delivery of oxaliplatin to tumor tissue by nanocarrier system enhances overall therapeutic efficacy of the encapsulated oxaliplatin. Biological and Pharmaceutical Bulletin, 37(2): 206-211.
Lindsten, T., Ross, A.J., King, A., Zong, W.-X., Rathmell, J.C., Shiels, H.A., Ulrich, E., Waymire, K.G., Mahar, P. and Frauwirth, K. 2000. The combined functions of proapoptotic bcl-2 family members bak and bax are essential for normal development of multiple tissues. Molecular cell, 6(6): 1389-1399.
Nankali, E., Shaabanzadeh, M. and Torbati, M.B. 2020. Fluorescent tamoxifen-encapsulated nanocapsules functionalized with folic acid for enhanced drug delivery toward breast cancer cell line mcf-7 and cancer cell imaging. Naunyn-Schmiedeberg's archives of pharmacology, 393(7): 1211-1219.
Olsen, S.N., Wronski, A., Castaño, Z., Dake, B., Malone, C., De Raedt, T., Enos, M., DeRose, Y.S., Zhou, W. and Guerra, S. 2017. Loss of rasgap tumor suppressors underlies the aggressive nature of luminal b breast cancers. Cancer discovery, 7(2): 202-217.
Papaliagkas, V., Anogianaki, A., Anogianakis, G. and Ilonidis, G. 2007. The proteins and the mechanisms of apoptosis: A mini-review of the fundamentals. Hippokratia, 11(3): 108.
Saxena, M., Kryworuchko, M. and Kumar, A. 2009. Anti-apoptotic genes in the survival of monocytic cells during infection. Current genomics, 10(5): 306-317.
Singh, S.K., Banala, V.T., Gupta, G.K., Verma, A., Shukla, R., Pawar, V.K., Tripathi, P. and Mishra, P.R. 2015. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in mcf-7 cells. Drug development and industrial pharmacy, 41(11): 1759-1768.
Thomas, S., Thurn, K.T., Biçaku, E., Marchion, D.C. and Münster, P.N. 2011. Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy. Breast cancer research and treatment, 130(2): 437-447.
Wang, Q., Jiang, J., Ying, G., Xie, X.-Q., Zhang, X., Xu, W., Zhang, X., Song, E., Bu, H. and Ping, Y.-F. 2018. Tamoxifen enhances stemness and promotes metastasis of erα36+ breast cancer by upregulating aldh1a1 in cancer cells. Cell research, 28(3): 336-358.